• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations

    10/17/24 9:05:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology
    Get the next $DH alert in real time by email

    FRAMINGHAM, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and participation for life science organizations by providing medical affairs, marketing, and conference planning teams with rich, contextualized conference data and access to the experts driving conference activities.

    By delivering a comprehensive overview of key conference insights—including information about presenters, timing, and locations of the most relevant scientific and medical updates—Monocl Conferences can help biopharma and medtech organizations make the most of every conference.

    Key features of Monocl Conferences include:

    • Visualized conference data: A user-friendly dashboard delivers powerful data visualization, making key insights easy to understand and eliminating the need for cumbersome spreadsheets.
    • Searchable conference insights: Users can quickly find relevant sessions, speakers, and topics across numerous presentations to identify important discussions and data readouts to attend.
    • Comparable data: Organizations can monitor year-over-year trends, presentations, topics, and conference activity of other key players across the industry with historical conference data for deeper insights.

    "We understand the vital role that conferences play in the biopharma and medtech industries," said Kristoffer Gustafsson, VP Platform Monocl at Definitive Healthcare. "Monocl Conferences is designed to streamline the planning process, drive strategic engagement, and ultimately support organizations in delivering innovative therapies and medical devices that improve patient outcomes."

    Monocl Conferences offers quick access to presentations, allowing users to uncover both their and their competitors' share of the program. Additionally, the platform provides insights into conference discussions via social media listening, revealing trending topics and key online contributors, along with access to presentation titles and abstracts that highlight conference focus areas and details about the presence of centers of excellence.

    Monocl Conferences is tailored to support diverse teams within life science organizations. It can help enhance scientific communication and expert engagement for medical affairs teams, streamline event organization and execution for conference planners, and provide marketing teams with insights to inform their conference selection, messaging, and presence. Together, these capabilities enable organizations to refine their conference strategies and derive maximum value from every event.

    For more information about Monocl Conferences, visit definitivehc.com/conferences.

    About Definitive Healthcare

    At Definitive Healthcare, our mission is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow's healthcare industry. Our SaaS products and solutions create new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

    Media Contacts:

    Bethany Swackhamer

    [email protected]

    Investor Relations Contact:

    Brian Denyeau

    ICR for Definitive Healthcare

    [email protected]



    Primary Logo

    Get the next $DH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is Monocl Conferences and what purpose does it serve?

      Monocl Conferences is a new solution launched by Definitive Healthcare to enhance conference planning and participation for life science organizations.

    • What are some of the key features offered by Monocl Conferences?

      Key features of Monocl Conferences include visualized conference data, searchable conference insights, and comparable data for monitoring industry trends.

    • What type of conference insights does Monocl Conferences provide for users?

      Monocl Conferences provides a comprehensive overview of key conference insights such as information about presenters, timing, and locations of relevant scientific and medical updates.

    • Which teams within life science organizations can benefit from Monocl Conferences?

      Monocl Conferences is tailored to support various teams within life science organizations, including medical affairs, conference planners, and marketing teams.

    • What is Definitive Healthcare's mission regarding healthcare commercial intelligence?

      Definitive Healthcare aims to transform data and analytics into healthcare commercial intelligence to help clients identify market opportunities and enhance commercial strategies.

    Recent Analyst Ratings for
    $DH

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    1/13/2025$4.00Equal Weight → Underweight
    Barclays
    12/20/2024$5.00Equal-Weight
    Stephens
    9/17/2024$7.00Buy
    BTIG Research
    7/31/2024$7.00 → $5.00Neutral → Underweight
    JP Morgan
    5/8/2024$11.50 → $9.00Overweight → Equal-Weight
    Morgan Stanley
    1/17/2024Buy → Hold
    Needham
    1/5/2024Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $DH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Coop Kevin

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    4/3/26 4:15:14 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Krantz Jason Ronald

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    4/3/26 4:15:13 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Coop Kevin covered exercise/tax liability with 175,524 shares, decreasing direct ownership by 3% to 5,116,465 units (SEC Form 4)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    3/3/26 4:05:11 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    SEC Filings

    View All

    Definitive Healthcare Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    4/9/26 4:05:08 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-K filed by Definitive Healthcare Corp.

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    4/3/26 4:05:10 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 filed by Definitive Healthcare Corp.

    S-8 - Definitive Healthcare Corp. (0001861795) (Filer)

    2/26/26 4:49:15 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Definitive Healthcare downgraded by BTIG Research

    BTIG Research downgraded Definitive Healthcare from Buy to Neutral

    5/9/25 8:41:31 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Definitive Healthcare from Equal Weight to Underweight and set a new price target of $4.00

    1/13/25 7:41:23 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Stephens initiated coverage on Definitive Healthcare with a new price target

    Stephens initiated coverage of Definitive Healthcare with a rating of Equal-Weight and set a new price target of $5.00

    12/20/24 7:31:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

    FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.  Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million, or (28)% of revenue, compared to $(84.7) million in Q4 2024, inclusive of goodwill impairment charges of $97.1 million, or (136)% of revenue.Adjusted Net Income was $8.6 million, compared to $12.6 millio

    2/26/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244

    1/29/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

    FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference. The Definitive Healthcare presentation is scheduled for Wednesday, January 14, 2026, at 9:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the Definitive Healthcare investor relations website at https://ir.definitivehc.com/. A replay of the webcast will also be available for a limited time. About Definitive HealthcareDefinitive Healthcare is a data and analytics company focu

    1/7/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Leadership Updates

    Live Leadership Updates

    View All

    Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

    FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a

    5/28/24 8:00:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

    Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv

    11/28/23 5:00:00 PM ET
    $DH
    $GDRX
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer

    FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and

    10/5/23 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    11/12/24 11:54:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    10/3/24 9:08:57 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Definitive Healthcare Corp. (Amendment)

    SC 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

    2/14/24 4:00:33 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Financials

    Live finance-specific insights

    View All

    Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

    FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.  Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million, or (28)% of revenue, compared to $(84.7) million in Q4 2024, inclusive of goodwill impairment charges of $97.1 million, or (136)% of revenue.Adjusted Net Income was $8.6 million, compared to $12.6 millio

    2/26/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244

    1/29/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

    FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.  Third Quarter 2025 Financial Highlights: Revenue was $60.0 million, a decrease of 4% from $62.7 million in Q3 2024. Net Loss was $(17.8) million, or (30)% of revenue, compared to $(187.8) million in Q3 2024, inclusive of goodwill impairment charges of $228.2 million, or (300)% of revenue.Adjusted Net Income was $9.7 million, compared to $15.4 million in Q3 2024.Adjusted EBITDA was $18.9 million, or 32% of revenue, compar

    11/6/25 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology